Venus Concept INC

Venus Concept Inc. has secured waivers for minimum liquidity requirements and extended its bridge loan maturity date to February 13, 2026, while drawing an additional $2 million for working capital.

Venus Concept Inc. announced its voluntary delisting from Nasdaq and deregistration with the SEC, alongside securing short-term waivers for loan liquidity requirements and a brief extension of its bridge loan maturity date.

Venus Concept Inc. obtained waivers for liquidity requirements and extended a bridge loan maturity date, converting an upcoming interest payment to principal.

Venus Concept Inc. has secured critical amendments to its loan agreements, extending maturity dates and waiving liquidity requirements through December 31, 2025, while also receiving a $1.5 million bridge loan drawdown.

Venus Concept Inc. reported an increased net loss for the third quarter of 2025, alongside the significant announcement of FDA clearance for its new multi-application Venus NOVA platform.

Venus Concept Inc. announced a consent agreement for its Main Street Priority Loan, a twenty-first amendment to its Bridge Loan extending maturity, and a new $2 million drawdown for working capital.

Venus Concept Inc. reported a significantly increased net loss and revenue decline for Q3 2025, exacerbated by geopolitical conflicts and substantial debt extinguishment losses, while its Venus Hair Business sale faces legal challenges.

Venus Concept Inc. reported a decrease in Q2 2025 revenue and gross profit, alongside a worsening Adjusted EBITDA loss, while announcing the sale of its Venus Hair Business for $20 million.

Venus Concept Inc.'s Q1 2025 revenue decreased by 21.9% year-over-year to $13.6 million, impacted by tighter credit markets, strategic shifts, and economic uncertainty.

Venus Concept Inc. reported its Q3 2024 financial results, showing a decrease in revenue and a net loss, while continuing its strategic review process.

Venus Concept's Q2 2024 results show a decrease in revenue and a net loss, while the company continues its strategic review process.

Venus Concept Inc. reported a net loss of $9.8 million for the first quarter of 2024, alongside a strategic review of alternatives to enhance shareholder value.

Venus Concept Inc.'s 2024 10-K filing reveals ongoing financial challenges, including recurring losses and a strategic review for maximizing shareholder value.

Venus Concept Inc.'s annual 10-K filing details its financial status, stock information, and corporate governance practices.

Madryn Asset Management and affiliated funds significantly increase their beneficial ownership in Venus Concept Inc. through multiple equity and debt transactions.

EW Healthcare Partners has sold its entire reported holdings in Venus Concept Inc.'s convertible preferred stock and notes to Madryn Health Partners for $2.6 million.

Madryn Asset Management and affiliates exchanged over $11 million in convertible notes for Series Y Convertible Preferred Stock in Venus Concept Inc.

Venus Concept Inc. has restructured its capital obligations by exchanging existing secured subordinated convertible notes held by Madryn Asset Management and its affiliates for new notes and Series Y Convertible Preferred Stock.

Madryn Asset Management and related entities report transactions involving Venus Concept Inc.'s convertible notes and preferred stock, including an exchange of existing notes for new notes and preferred stock.

A Venus Concept director, Anthony Natale, sold 42,768 common shares at an average price of $0.3085 per share.

Venus Concept Inc. has issued a supplement to its 2025 Annual and Special Meeting proxy statement, clarifying Proposal No. 6 related to the issuance of common stock upon conversion of new Secured Subordinated Convertible Notes, which were part of a debt restructuring initiative that reduced outstanding debt by approximately $50 million and cured a Nasdaq listing deficiency.

Venus Concept is asking stockholders to approve the issuance of common stock upon the conversion of several series of preferred stock and a convertible note at the upcoming Annual and Special Meeting of Stockholders on June 25, 2025.

Venus Concept Inc. is asking stockholders to approve a reverse stock split to regain compliance with Nasdaq's minimum bid price requirement.

Venus Concept Inc. will hold its Annual Meeting of Stockholders online on June 5, 2024, to elect directors and ratify the selection of its independent accounting firm.

Venus Concept Inc. has filed an Amendment No. 1 to its Form S-1 Registration Statement, primarily to incorporate the consent of its independent registered public accounting firm, MNP LLP.

Venus Concept Inc. has filed an S-1 registration statement for the resale of up to 899,870 common shares by selling stockholders, following a recent $1.15 million registered direct offering and the planned $20 million sale of its Hair Business.

Venus Concept has filed a registration statement for the resale of up to 874,990 shares of its common stock by selling stockholders, which are issuable upon the exercise of outstanding warrants.

EW Healthcare Partners and its affiliates have filed an Amendment No. 18 to Schedule 13D, reporting that they no longer beneficially own any shares of Venus Concept, Inc. common stock.

Madryn Asset Management completed a short-form merger, acquiring all outstanding common stock of Venus Concept Inc. for $0.04 per share, taking the company private.

EW Healthcare Partners has sold a significant portion of its holdings in Venus Concept, Inc. to Madryn Asset Management for $2.6 million.

EW Healthcare Partners and affiliates have agreed to sell their preferred stock and convertible debt holdings in Venus Concept Inc. to Madryn Asset Management for $2.6 million.

Madryn Asset Management proposes a comprehensive debt-for-equity restructuring and short-form merger for Venus Concept Inc., valuing common stock at $0.01 per share.

Madryn Asset Management, a major shareholder, proposes a debt-for-equity swap and new financing for Venus Concept, potentially leading to majority ownership and discussing delisting.

Intracoastal Capital LLC, along with Mitchell P. Kopin and Daniel B. Asher, has filed a Schedule 13G disclosing beneficial ownership of 4.99% of Venus Concept Inc.'s common stock, primarily through warrants with blocker provisions.

Orca Capital AG has filed an amended Schedule 13G, disclosing a 4.9% beneficial ownership stake in Venus Concept Inc., holding 101,748 common shares.

Orca Capital AG has filed an amended Schedule 13G, reporting a 5.9% beneficial ownership stake in Venus Concept Inc., holding 108,680 shares of common stock.

Intracoastal Capital LLC, along with Mitchell P. Kopin and Daniel B. Asher, has disclosed a beneficial ownership of 2.6% in Venus Concept Inc.'s common stock, totaling 37,776 shares.

Orca Capital AG has filed an amended Schedule 13G, indicating it no longer beneficially owns any common stock of Venus Concept Inc.

Orca Capital AG has reported a passive 8.0% beneficial ownership stake in Venus Concept Inc., holding 83,429 shares of common stock.